Related Experiment Video
Updated: Jul 16, 2026
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
Interventional neuroradiology: the role of experimental models in scientific progress
J Raymond1, I Salazkin, G Gevry
1Department of Radiology, Centre Hospitalier de l'Université de Montréal, Notre-Dame Hospital, Montreal, Canada. dr_jean_raymond@hotmail.com
Summary:
The ultimate methodology necessary to adopt a treatment as generally beneficial is the randomized controlled trial, a method designed by and for clinicians to maximize the care of their patients in the presence of uncertainty. Some selection is however necessary to limit trials to more promising and less risky endeavors. Experimental models are the privileged answer to the problem of finding scientific evidence while refraining from harming patients in the course of this pursuit. They allow a step by step assessment, from simple but artificial settings to more complex and realistic animal models. But the use of animal models can only be justified if the community can be convinced that alternatives have been considered but are invalid, when the project is scientifically sound and methodologically irreproachable. As neurointerventional methods develop and gain wider clinical applications, progress should proceed in an orderly fashion, within limits set by prudence and human values, from the less risky, costly, time consuming methods, to the more definite, pragmatic, labor intensive but inescapable clinical trials. Each step is essential and the sequence cannot be violated without risks of errors that eventually translate into clinical morbidity.
Insights
Randomized controlled trials are essential for confirming treatment benefits. Experimental models, including animal studies, provide crucial evidence while minimizing patient harm, guiding clinical progression responsibly.
Area of Science:
- Neuroscience
- Clinical Research Methodology
- Medical Ethics
Background:
- Neurointerventional methods are rapidly advancing, necessitating rigorous evaluation before widespread clinical adoption.
- Ethical considerations and patient safety are paramount in developing new medical treatments.
- A structured approach is required to transition from experimental findings to clinical application.
Purpose of the Study:
- To outline a stepwise methodology for evaluating the efficacy and safety of neurointerventional treatments.
- To emphasize the role of experimental models in preclinical assessment.
- To establish the necessity of randomized controlled trials for definitive treatment validation.
Main Methods:
- Utilizing experimental models, progressing from in vitro to in vivo animal studies, to gather preliminary scientific evidence.
- Conducting a thorough review of alternative methods to justify the use of animal models.
- Designing scientifically sound and methodologically rigorous research protocols.
Main Results:
- Experimental models allow for a phased assessment of treatment potential, reducing risks associated with direct human experimentation.
- A clear justification for animal model use is required, based on the consideration and invalidation of alternatives.
- Progressive evaluation, from simpler models to complex animal studies, precedes human clinical trials.
Conclusions:
- Randomized controlled trials are the gold standard for establishing general treatment benefit.
- A sequential, evidence-based approach, incorporating experimental models and ethical considerations, is vital for safe neurointerventional method development.
- Violating the established research sequence risks clinical errors and patient harm.